Business
Medical Marijuana, Inc. and Subsidiaries' 2019 Sales Bookings Surpass Total 2018 Sales Bookings
Medical Marijuana, Inc. and Subsidiaries' 2019 Sales Bookings Surpass Total 2018 Sales Bookings.
About this update from Medical Marijuana, Inc.
[{"type":"text","content":"\n\n\n\nMedical Marijuana, Inc. and Subsidiaries' 2019 Sales Bookings Surpass Total 2018 Sales Bookings\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n\n\n\n\n\n\nMedical Marijuana, Inc. and Subsidiaries' 2019 Sales Bookings Surpass Total 2018 Sales Bookings\nPR Newswire\nSAN DIEGO, Nov. 5, 2019\n\n\n\nSAN DIEGO, Nov. 5, 2019 /PRNewswire/ -- Medical Marijuana, Inc. (\"the Company\") (OTC: MJNA), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its portfolio of companies' 2019 sales bookings has surpassed its total 2018 sales bookings. \n\"We set our goals high for this year and it's encouraging to see that our team worked diligently to achieve and surpass them,\" said Medical Marijuana, Inc. CEO Dr. Stuart Titus. \"By entering new markets and releasing many new products to meet the versatile needs of our customers, our efforts will further position us as a major contributor to the expanding global cannabis industry.\" \nMedical Marijuana, Inc. is a major producer of cannabidiol (CBD) products in the U.S., European, Latin American and Asian markets with distribution subsidiaries Kannaway®, HempMeds®, Dixie Botanicals®. This portfolio of companies provides customers with a variety of oral, topical and edible CBD products that are Triple Lab Tested™ to ensure the highest standard of quality and consistency. \n\"It's predicted by the Brightfield Group that 2019 CBD product sales could grow 706% compared to 2018 sales figures and could reach upwards of $5 billion,\" said Medical Marijuana, Inc. COO Blake Schroeder. \"It's been exhilarating to watch this industry expand exponentially since its infancy and we look forward to witnessing its future success in years to come.\"\nEarlier this year, the Company was named a top-five CBD producer by equity research firm Avise Analytics and was awarded a Bronze Stevie® Award for Most Innovative Company of the Year in the 16th Annual International Business Award...